Cargando…

Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled, confirmatory phase III trial

INTRODUCTION: The efficacy of a cholinesterase inhibitor, donepezil, in patients with dementia with Lewy bodies (DLB) was investigated to confirm the superiority over placebo in the 12-week, double-blind phase of this phase III study. METHODS: Patients with probable DLB (n = 142) were randomly assig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Manabu, Mori, Etsuro, Matsuo, Kazutaka, Nakagawa, Masaki, Kosaka, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338565/ https://www.ncbi.nlm.nih.gov/pubmed/25713599 http://dx.doi.org/10.1186/s13195-014-0083-0

Ejemplares similares

Long-term donepezil use for dementia with Lewy bodies: results from an open-label extension of Phase III trial
por: Mori, Etsuro, et al.
Publicado: (2015)

Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
por: Mori, Etsuro, et al.
Publicado: (2012)

Aphasic mild cognitive impairment in prodromal dementia with Lewy bodies
por: Watanabe, Hiroyuki, et al.
Publicado: (2023)

Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014)

Primary Progressive Aphasia as a Prodromal State of Dementia With Lewy Bodies: A Case Report
por: Watanabe, Hiroyuki, et al.
Publicado: (2020)

Potential Role of the Sigma-1 Receptor Chaperone in the Beneficial Effects of Donepezil in Dementia with Lewy Bodies
por: Hashimoto, Kenji
Publicado: (2013)

Improvement of Visuo-spatial Function Assessed by Raven’s Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment
por: Yoshino, Yuta, et al.
Publicado: (2017)

Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL Study
por: Ikeda, Manabu, et al.
Publicado: (2023)

Case report: Delusional infestation in dementia with Lewy bodies
por: Taomoto, Daiki, et al.
Publicado: (2022)

Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients
por: Hashimoto, Mamoru, et al.
Publicado: (2015)

Pareidolias: complex visual illusions in dementia with Lewy bodies
por: Uchiyama, Makoto, et al.
Publicado: (2012)

Effect of donepezil for dementia prevention in Parkinson's disease with severe hyposmia (The DASH-PD study): A randomized long-term placebo-controlled trial
por: Baba, Toru, et al.
Publicado: (2022)

Case Report: De Clerambault's Syndrome in Dementia With Lewy Bodies
por: Suehiro, Takashi, et al.
Publicado: (2021)

A prospective multicenter validation study of a machine learning algorithm classifier on quantitative electroencephalogram for differentiating between dementia with Lewy bodies and Alzheimer’s dementia
por: Suzuki, Yukiko, et al.
Publicado: (2022)

Logopenic aphasia due to Lewy body disease dramatically improved with donepezil
por: Kakinuma, Kazuo, et al.
Publicado: (2020)

Impact of Behavioral and Psychological Symptoms on Caregiver Burden in Patients With Dementia With Lewy Bodies
por: Kanemoto, Hideki, et al.
Publicado: (2021)

Behavioural and Cognitive Changes in Lewy Body Dementias
por: Kung, Woon-Man, et al.
Publicado: (2018)

Changes in pupil diameter are correlated with the occurrence of pareidolias in patients with dementia with Lewy bodies
por: Suzuki, Yumi, et al.
Publicado: (2017)

Dementia with Lewy bodies
por: McKeith, Ian
Publicado: (2004)

Dementia with Lewy bodies research consortia: A global perspective from the ISTAART Lewy Body Dementias Professional Interest Area working group
por: D'Antonio, Fabrizia, et al.
Publicado: (2021)

Diagnostic Accuracy of (123)I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study
por: Yoshita, Mitsuhiro, et al.
Publicado: (2015)

Neuroimaging in Lewy body dementia
por: Yousaf, Tayyabah, et al.
Publicado: (2018)

Microbleeds in dementia with Lewy bodies
por: Donaghy, Paul C., et al.
Publicado: (2020)

Advances in dementia with Lewy bodies
por: Armstrong, Melissa J.
Publicado: (2021)

Neuroimaging in Dementia With Lewy Bodies
por: Saha, Abhishikta, et al.
Publicado: (2021)

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo‐Controlled Trial
por: Biglan, Kevin, et al.
Publicado: (2021)

Anosognosia in dementia with Lewy bodies: a systematic review
por: CALIL, Victor, et al.
Publicado: (2021)

Research criteria for the diagnosis of prodromal dementia with Lewy bodies
por: McKeith, Ian G., et al.
Publicado: (2020)

Neuroimaging characteristics of dementia with Lewy bodies
por: Mak, Elijah, et al.
Publicado: (2014)

Comprehensive treatment of dementia with Lewy bodies
por: Boot, Brendon P
Publicado: (2015)

Neurophysiological biomarkers for Lewy body dementias
por: Cromarty, Ruth A., et al.
Publicado: (2016)

Exome sequencing in dementia with Lewy bodies
por: Keogh, M J, et al.
Publicado: (2016)

Clinical prevalence of Lewy body dementia
por: Kane, Joseph P. M., et al.
Publicado: (2018)

Dementia with Lewy bodies: an update and outlook
por: Outeiro, Tiago Fleming, et al.
Publicado: (2019)

Young-Onset Dementia with Lewy Bodies
por: Aiba, Yosuke, et al.
Publicado: (2018)

Pharmacological Management of Dementia with Lewy Bodies
por: Hershey, Linda A., et al.
Publicado: (2019)

Spatial Perseveration in Dementia with Lewy Bodies
por: Assal, Frédéric, et al.
Publicado: (2007)

Clinical diagnosis of Lewy body dementia
por: Surendranathan, Ajenthan, et al.
Publicado: (2020)

Gut microbiota in dementia with Lewy bodies
por: Nishiwaki, Hiroshi, et al.
Publicado: (2022)

Onset matters in dementia with Lewy bodies
por: Müller, Sebastian Johannes, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ea3b84k9s1d05thh3h77e9rkif